White & Case advised Ormat, and Davis Polk advised the sole book-running manager. Ormat Technologies, Inc. announced an SEC-registered follow-on offering of 3,600,000 shares of common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Marsh McLennan, and Willkie Farr & Gallagher advised the underwriters. Marsh McLennan announced its SEC-registered offering of $600 million of its 5.450% senior...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Central American Bank for Economic Integration, and Davis Polk advised the initial purchasers of the notes. Central American Bank for Economic...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and Latham & Watkins advised General Motors Financial on the offering. General Motors Financial Company Inc. announced an SEC-registered offering...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the initial purchasers on the offering. Axon Enterprise, Inc. announced its offering of $690 million aggregate principal amount of 0.50% convertible...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk & Wardwell advised the representatives of the several underwriters. Prometheus Biosciences,...
You must be a Standard 1 Year member to access this content.
White & Case advised Ormat Technologies, Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. Kirkland advised ORIX Corporation....
You must be a Standard 1 Year member to access this content.
Davis Polk advised Marsh McLennan in the offering, while Willkie advised the underwriters. Marsh McLennan announced its offering of $500 million of its 5.750% senior notes...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the placement agents in the transaction. Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented NextGen Healthcare, while Davis Polk advised J.P. Morgan Securities LLC, the representative of the initial purchasers in the offering. NextGen Healthcare, Inc....
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell LLP and Mattos Filho, Veiga Filho, Marrey Jr. e Quiroga Advogados advised Arco, while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP...
You must be a Standard 1 Year member to access this content.
Davis Polk advised GeoPark Limited on the transaction. GeoPark Limited announced a solicitation of consents from holders of its 5.500% senior notes due 2027 to effect...
You must be a Standard 1 Year member to access this content.
